Fragile X study offers hope of new autism treatment: McGill prof

This is exciting, even if it does affect only those with a certain type of autism.

The scientists, who have identified a chemical pathway that goes awry in the brains of Fragile X patients, say a cancer drug candidate could reverse their behavioural symptoms. The researchers have found that a naturally occurring anti-fungal called cercosporamide can block the pathway and improve sociability in mice with the condition.